Thy-1-mediated activation of rat mast cells: the role of Thy-1 membrane microdomains
Language English Country Great Britain, England Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
8666426
PubMed Central
PMC1383980
Knihovny.cz E-resources
- MeSH
- Thy-1 Antigens immunology MeSH
- Cell Membrane immunology MeSH
- Cholesterol physiology MeSH
- Detergents MeSH
- Electrophoresis, Polyacrylamide Gel MeSH
- Fluorescent Antibody Technique MeSH
- Rats MeSH
- Humans MeSH
- Mast Cells immunology MeSH
- Molecular Sequence Data MeSH
- Mice MeSH
- Precipitin Tests MeSH
- Base Sequence MeSH
- src-Family Kinases metabolism MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Humans MeSH
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Thy-1 Antigens MeSH
- Cholesterol MeSH
- Detergents MeSH
- lyn protein-tyrosine kinase MeSH Browser
- src-Family Kinases MeSH
The glycosyl-phosphatidylinositol (GPI)-anchored glycoprotein Thy-1 is one of the most abundant molecules expressed on the surface of rat mast cells and rat basophilic leukemia (RBL) cells. The finding that Thy-1 from detergent-solubilized RBL-2H3 cells forms complexes with src-related protein-tyrosine kinase p56/p53lyn suggested that this kinase may play a key role in Thy-1-mediated mast-cell activation. The molecular mechanism of this activation is, however, unknown. Here we show that in RBL-2H3-derived cells extracted by the standard procedure with several non-ionic detergents, the majority of Thy-1 and p56/p53lyn were not released into postnuclear supernatant but remained associated with the detergent-resistant cytoskeletal/nuclear fraction. Pretreatment of the cells with the cholesterol-complexing agents, saponin or digitonin, resulted in complete solubilization of Thy-1 and p56/p53lyn in non-ionic detergents and dissociation of the complexes; this implies that cholesterol plays a crucial role in stabilization of the complexes. This conclusion was supported by double immunofluorescence colocalization experiments which also allowed us to estimate the size of the insoluble complexes to be about 0.1 micron. Sequential treatment with saponin and Nonidet P-40 was used to fractionate tyrosine-phosphorylated proteins during Thy-1-mediated activation of RBL-2H3 cells. Among the soluble cytoplasmic proteins the most dramatic change in tyrosine phosphorylation was found in pp72, whereas pp40 and pp33 were found mainly in the membrane fraction. Our data suggest that surface aggregation of GPI-anchored Thy-1 molecules leads to aggregation of p56/p53lyn kinase located in the same membrane microdomain, followed by transphosphorylation of both soluble and membrane-bound substrates.
See more in PubMed
J Biol Chem. 1994 Feb 18;269(7):5249-54 PubMed
J Cell Biol. 1992 Jul;118(1):63-9 PubMed
J Immunol. 1992 Oct 1;149(7):2262-70 PubMed
J Immunol. 1992 Dec 1;149(11):3535-41 PubMed
J Biol Chem. 1993 Feb 15;268(5):3150-5 PubMed
Eur J Immunol. 1993 Apr;23(4):825-31 PubMed
Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3611-5 PubMed
Immunol Today. 1993 May;14(5):222-6 PubMed
Immunology. 1993 Sep;80(1):103-9 PubMed
J Cell Biol. 1994 Jul;126(1):111-26 PubMed
J Cell Biol. 1994 Jul;126(2):353-63 PubMed
Mol Cell Biol. 1994 Aug;14(8):5384-91 PubMed
Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):11246-50 PubMed
Biochim Biophys Acta. 1984 Jun 13;773(1):32-8 PubMed
Mol Cell Biol. 1987 Jan;7(1):237-43 PubMed
Biochem J. 1988 Mar 15;250(3):865-9 PubMed
FASEB J. 1989 Mar;3(5):1600-8 PubMed
Eur J Immunol. 1989 Sep;19(9):1715-20 PubMed
J Immunol. 1990 Dec 1;145(11):3814-22 PubMed
J Cell Biol. 1990 Dec;111(6 Pt 2):2931-8 PubMed
Eur J Immunol. 1991 Jul;21(7):1583-90 PubMed
Science. 1991 Nov 15;254(5034):1016-9 PubMed
Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):222-6 PubMed
Proc Natl Acad Sci U S A. 1992 Feb 1;89(3):1118-22 PubMed
Cell. 1992 Feb 7;68(3):533-44 PubMed
Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2945-9 PubMed
J Biol Chem. 1994 Dec 9;269(49):30745-8 PubMed
J Cell Sci. 1994 Jul;107 ( Pt 7):1783-96 PubMed
J Biol Chem. 1992 Jun 15;267(17):12317-22 PubMed
Nature. 1970 Aug 15;227(5259):680-5 PubMed
Eur J Immunol. 1979 Nov;9(11):875-86 PubMed
Biochem J. 1980 Apr 1;187(1):1-20 PubMed
Anal Biochem. 1984 Feb;136(2):458-64 PubMed
Science. 1994 Jun 24;264(5167):1948-51 PubMed
ORMDL2 Deficiency Potentiates the ORMDL3-Dependent Changes in Mast Cell Signaling